(Q37340992)

19 August 2017

Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana (English)

1 reference

19 August 2017

0 references

anti-retroviral agent

0 references

1

Gregory P Bisson

1 reference

19 August 2017

Adam Rowh

2

1 reference

19 August 2017

Rachel Weinstein

3

1 reference

19 August 2017

Tendani Gaolathe

4

1 reference

19 August 2017

Ian Frank

5

1 reference

19 August 2017

Robert Gross

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

Journal of Acquired Immune Deficiency Syndromes

19 August 2017

1 reference

19 August 2017

49

1 reference

19 August 2017

1

1 reference

19 August 2017

107-110

1 reference

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Antiretroviral therapy in a thousand patients with AIDS in Haiti

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

A Simple, Dynamic Measure of Antiretroviral Therapy Adherence Predicts Failure to Maintain HIV‐1 Suppression

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5065011

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002

3 December 2018

1 reference

12 December 2020

"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy

1 reference

12 December 2020

The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients

1 reference

12 December 2020

Estimating odds ratios with categorically scaled covariates in multiple logistic regression analysis

1 reference

12 December 2020

1 reference

12 December 2020

A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV

1 reference

12 December 2020

10.1097/QAI.0B013E3181820141

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference